Is Amgen Inc. (AMGN) a buy today?
Amgen Inc. currently carries an AI verdict of under review. Use that as a research starting point alongside price structure, risk score, and live news rather than as financial advice.
Our AI Committee has evaluated Amgen Inc. (AMGN) and currently issues a Neutral verdict. The 14-day RSI currently reads 41.6, indicating a neutral momentum regime with room to trend in either direction.
Macro Desk — Global Picture & Capital Flows
System Summary: Promoters pledged 11% of holdings. Major red flag. 🚩
Quant Desk — Algorithmic & Technical Signals
Technicals (Neutral RSI): Low Vol
Fundamental Desk — Valuation & Financial Health
Fundamentals: Delivery Low Delivery, Debt: Low Debt
This analysis is generated by MicroStocks' multi-agent AI committee and is refreshed every hour. Learn how our AI generates these verdicts →
AI Market Briefing
P/E Ratio
24.2x
50-Day SMA
$361.11
Beta
0.47
Market Cap
$185.7B
Amgen Inc. currently carries an AI verdict of under review. Use that as a research starting point alongside price structure, risk score, and live news rather than as financial advice.
A live Micro-Score is not available for AMGN right now, but the page still tracks its verdict, risk profile, and market action.
The live technical stack on this page tracks RSI at 41.6, the 20-day moving average at $348.88, and the 50-day moving average at $361.11 to frame momentum and trend alignment.
Canonical: https://www.microstocks.in/stock/AMGN
Our AI Committee currently assigns a Neutral verdict for Amgen Inc.. The 14-day RSI stands at 41.6, placing it in a neutral momentum regime.
AI Committee analysis is currently being computed for AMGN. Check back shortly.